Clinical Trial

PMCF Study of Precise Pro Rx for Carotid Artery Disease

Study acronym: REAL-PRECISE
Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate long-term clinical safety and performance of the PRECISE PRO RX Nitinol Stent System to treat stenotic lesions of the carotid arteries.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-24; most recent amendment 2026-03-11.
Status change: Enrolling by Invitation → Completed 2026-03-11
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-01-01
Trial Details
NCT Number NCT07204678
Lead Sponsor Cordis US Corp.
Collaborators: Rede Optimus Hospitalar SA
Conditions Carotid Artery Stenosis
Enrollment 199 participants
Start Date 2025-10-30
Primary Completion 2026-02-27 (estimated)
Study Completion 2026-02-27 (estimated)
Updated on ClinicalTrials.gov 2026-03-13